| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7aaea2e6a1d9bdb1c843bfe784e79c9e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
| filingDate |
2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94374c6b8daeab898e7e42da01da21a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99db05a47ed55ec64021bdada80583a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb788fa1fc928c346047e514349ed143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a766ac2a30ad738d1cd073cca4bc2411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e66e255b206e685653de2ee88dbaf211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd8327f82a6caa7f7bc7bd90a6fe5a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a42cc3d07a8ea9e4600895144b20c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e579612aa7aca6975130e4758bdbe1b |
| publicationDate |
2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110092266-A |
| titleOfInvention |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| abstract |
Certain compounds are provided herein. Also provided are pharmaceutical compositions comprising at least one compound and one or more pharmaceutically acceptable vehicles. A method of treating a patient suffering from certain diseases and disorders responsive to the inhibition of KMO activity, the method comprising administering to the patient an amount of at least one compound effective to reduce the signs or symptoms of the disease or disorder. Is initiated. Such diseases include neurodegenerative diseases such as Huntington's disease. Also disclosed is a method of treatment comprising administering at least one compound as a single active agent, or administering at least one compound in combination with one or more other therapeutic agents. Also provided are methods for screening compounds that can inhibit KMO activity. |
| priorityDate |
2008-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |